LY3439539
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 21, 2026
A Study of LY3439539 in Participants With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: May 2027 ➔ Aug 2027 | Trial primary completion date: May 2027 ➔ Aug 2027
Biomarker • Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders • CSF NfL • Plasma NfL
June 17, 2026
A Study of LY3439539 in Participants With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Biomarker • Enrollment open • Alzheimer's Disease • CNS Disorders • CSF NfL • Plasma NfL
1 to 2
Of
2
Go to page
1